TrialDiabetes care2015

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.

Arthur T Sands et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.